Gefarnate: Clinical Trials

2 trials of Gefarnate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Gefarnate: new trials by email Literature Review of Gefarnate trials Research Report on Gefarnate

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation
Low-dose PPI (Rabeprazole sodium), High-dose PPI (Rabeprazole sodium), Non-PPI (Gefarnate) - Cardio-cerebrovascular Disease
Phase 3CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan2802008-08-012011-04-04
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
Lansoprazole, Gefarnate - Stomach Ulcer, Duodenal Ulcer
Phase 3CompletedTakeda3662007-04-012012-02-03

Conditions studied

Duodenal Ulcer (1)  ·  Stomach Ulcer (1)

Sponsors

Takeda (1)  ·  Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1)

Countries

Japan (2)

Top investigators

Takeshi Azuma, M.D., Ph.D. (1)